$0.5000-4.12%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Humacyte last closed at $0.5000 (-4.12%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -1.2×. Its overall grade ranks 681 of 741 stocks in Healthcare.
About this company
Humacyte last closed at $0.5000 (-4.12%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall F · 681/741
Valuation grade D
Related stocks
- Baxter InternationalCustomer
Humacyte의 혈관 이식재 상용화·유통 협력 대상
- MedtronicCompetitor
혈관·심혈관 수술용 의료기기 및 재건 치료 영역의 대형 경쟁사
- W. L. Gore & AssociatesCompetitor
혈관 이식재·혈관 대체재 분야의 강력한 경쟁 제품 보유
About Humacyte
- What technical signals does Humacyte (HUMA) have?
- Humacyte current technical signals: no active technical signal.
- Is Humacyte a cup-and-handle pattern?
- No. Humacyte has no valid Cup signal right now.
- What published figures are available for Humacyte?
- Market cap: $96.5M. Trailing 12 months PER: -1.2×. Latest quarter PBR: 3.75×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Humacyte, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy